Author

A. J. Craig

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Assay:metabolomics· 2 Approach:statistical model· 2 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

A. Azizian· 2 shared H. Cawley· 2 shared H. Liu· 2 shared J. Gaedcke· 2 shared M. Ghadimi· 2 shared N. Hanna· 2 shared P. Moreno· 2 shared S. Ambs· 2 shared

Activity by Year

2023-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Azizian

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

LMO3 is a suppressor of the basal-like/squamous PDAC subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism

Y. Ohara, A. J. Craig, H. Liu, S. Yang, P. Moreno, T. H. Dorsey, H. Cawley, A. Azizian, J. Gaedcke, M. Ghadimi, N. Hanna, S. Ambs, S. P. Hussain

This study identifies LMO3 as a suppressor of the aggressive basal-like/squamous PDAC subtype, showing it reduces disease aggressiveness through modulation of glycerol 3-phosphate metabolism.

Carcinogenesis · Feb 15, 2024Peer-reviewedCancer Biology

ELAPOR1 induces the classical/progenitor subtype and contributes to reduced disease aggressiveness through metabolic reprogramming in pancreatic cancer

Y. Ohara, A. J. Craig, H. Liu, S. Yang, P. Moreno, T. H. Dorsey, H. Cawley, A. Azizian, J. Gaedcke, M. Ghadimi, N. Hanna, S. Ambs, S. P. Hussain

This study identifies ELAPOR1 as a tumor suppressor in pancreatic cancer, showing its association with reduced disease aggressiveness and a metabolic signature of the classical/progenitor subtype.

bioRxiv · Sep 23, 2023Cancer Biology